These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19245509)

  • 21. The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective.
    Vuksan-Cusa B; Marcinko D; Sagud M; Jakovljević M
    Psychiatr Danub; 2009 Sep; 21(3):382-5. PubMed ID: 19794361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular risk factors among forensic patients in the acute psychiatric ward.
    Sazhin V; Reznik R
    Aust N Z J Psychiatry; 2008 Mar; 42(3):254. PubMed ID: 18247202
    [No Abstract]   [Full Text] [Related]  

  • 23. Protecting the heart while treating the mind. Preventing and treating heart disease in people with schizophrenia.
    Harv Ment Health Lett; 2007 Nov; 24(5):1-3. PubMed ID: 18271089
    [No Abstract]   [Full Text] [Related]  

  • 24. Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia.
    Kakunje A; Prabhu A; Priya Es S; Karkal R; Pookoth RK; Pd R
    J Clin Psychopharmacol; 2018 Dec; 38(6):652-653. PubMed ID: 30192255
    [No Abstract]   [Full Text] [Related]  

  • 25. Metformin to reduce weight gain and metabolic disturbance in schizophrenia.
    Faulkner G; Duncan M
    Evid Based Ment Health; 2015 Aug; 18(3):89. PubMed ID: 26081916
    [No Abstract]   [Full Text] [Related]  

  • 26. Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia.
    Oh N; See YM; Remington G; Lee J
    J Clin Psychopharmacol; 2016 Aug; 36(4):403-5. PubMed ID: 27187561
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical antipsychotics and weight gain.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Challenges in nutrition-based treatment for weight control in adolescents suffering from schizophrenia].
    Shani M; Levi M; Zalsman G
    Harefuah; 2008 Nov; 147(11):901-5, 939. PubMed ID: 19264012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing self-reported ethnicity and structure-determined ethnicity: analysis of antipsychotic-induced weight gain.
    De Luca V; Monda M; Chan LF
    Pharmacogenomics; 2013 Dec; 14(16):1943. PubMed ID: 24279847
    [No Abstract]   [Full Text] [Related]  

  • 30. Metformin as a treatment for antipsychotic drug side effects: special focus on women with schizophrenia.
    Smith RC
    Am J Psychiatry; 2012 Aug; 169(8):774-6. PubMed ID: 22854925
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mental disorders and heart disease].
    Aini-yet B
    Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2126-7. PubMed ID: 17717587
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential lower efficacy of molindone among first-generation antipsychotics.
    Waugaman RM
    Am J Psychiatry; 2009 Apr; 166(4):491; author reply 492-3. PubMed ID: 19339370
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
    Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
    Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergic reactions and sudden death with asenapine.
    Masters KJ
    J Clin Psychiatry; 2012 May; 73(5):720; author reply 720-1. PubMed ID: 22697198
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients.
    Sentissi O; Viala A; Bourdel MC; Kaminski F; Bellisle F; Olié JP; Poirier MF
    Int Clin Psychopharmacol; 2009 Sep; 24(5):257-64. PubMed ID: 19606055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One ace and three faults don't win the set.
    George D; Reilly JG; Kwentoh ML
    Br J Psychiatry; 2009 Jan; 194(1):88-9; author reply 89. PubMed ID: 19118335
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Chan et al. the difference between p < 0.05 and p < 0.05 is p > 0.05.
    Kaufman JS; Hamra G
    Pharmacogenomics; 2013 Dec; 14(16):1941-2. PubMed ID: 24279846
    [No Abstract]   [Full Text] [Related]  

  • 39. [Response to the position of the "Biological Psychiatry" Working Group of the Federal Directors Conference--Association of Executive Physicians of Psychiatry and Psychotherapy Clinics (BDK) e.V].
    Aderhold V
    Psychiatr Prax; 2009 Mar; 36(2):94-5. PubMed ID: 19358097
    [No Abstract]   [Full Text] [Related]  

  • 40. Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy.
    Sentissi O; Grouselle D; Viala A; Bourdel MC; Olié JP; Epelbaum J; Poirier MF
    J Clin Psychopharmacol; 2009 Jun; 29(3):304-6. PubMed ID: 19440091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.